My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 210

    1.

    Glycemic variability: should we and can we prevent it?

    Monnier L, Colette C.

    Diabetes Care. 2008 Feb;31 Suppl 2:S150-4.PMID: 18227477 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Acute glucose fluctuations and chronic sustained hyperglycemia as risk factors for cardiovascular diseases in patients with type 2 diabetes.

    Colette C, Monnier L.

    Horm Metab Res. 2007 Sep;39(9):683-6. Review.PMID: 17846977 [PubMed - indexed for MEDLINE]Related articles

    3.

    Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.

    Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C.

    JAMA. 2006 Apr 12;295(14):1681-7.PMID: 16609090 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Importance of postprandial glucose levels as a target for glycemic control in type 2 diabetes.

    Tibaldi J.

    South Med J. 2009 Jan;102(1):60-6. Review.PMID: 19077774 [PubMed - indexed for MEDLINE]Related articles

    5.

    How should postprandial glycemia be treated?

    Charpentier G, Dardari D, Riveline JP.

    Diabetes Metab. 2006 Sep;32 Spec No2:2S21-7. Review.PMID: 17375403 [PubMed - indexed for MEDLINE]Related articles

    6.

    Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: a move towards a unified glucose tetrad concept.

    Monnier L, Colette C, Owens DR.

    Diabetes Metab Res Rev. 2009 Jul;25(5):393-402. Review.PMID: 19437415 [PubMed - indexed for MEDLINE]Related articles

    7.

    Therapeutic potential of dipeptidyl peptidase-IV inhibitors in patients with diabetes mellitus.

    Moore KB, Saudek CD.

    Am J Ther. 2008 Sep-Oct;15(5):484-91. Review.PMID: 18806525 [PubMed - indexed for MEDLINE]Related articles

    8.

    Glycated and oxidized protein degradation products are indicators of fasting and postprandial hyperglycemia in diabetes.

    Ahmed N, Babaei-Jadidi R, Howell SK, Thornalley PJ, Beisswenger PJ.

    Diabetes Care. 2005 Oct;28(10):2465-71.PMID: 16186281 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    The role of self-monitoring of blood glucose during the treatment of type 2 diabetes with medications targeting postprandial hyperglycemia.

    Choe C, Edelman SV.

    South Med J. 2007 Nov;100(11):1123-31. Review.PMID: 17984745 [PubMed - indexed for MEDLINE]Related articles

    10.

    Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia.

    Wright E Jr, Scism-Bacon JL, Glass LC.

    Int J Clin Pract. 2006 Mar;60(3):308-14. Review.PMID: 16494646 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Defining the role of insulin lispro in the management of postprandial hyperglycaemia in patients with type 2 diabetes mellitus.

    Giugliano D, Ceriello A, Razzoli E, Esposito K.

    Clin Drug Investig. 2008;28(4):199-210. Review.PMID: 18345710 [PubMed - indexed for MEDLINE]Related articles

    12.

    The rationale for paired pre- and postprandial self-monitoring of blood glucose: the role of glycemic variability in micro- and macrovascular risk.

    Gerich JE, Odawara M, Terauchi Y.

    Curr Med Res Opin. 2007 Aug;23(8):1791-8.PMID: 17610805 [PubMed - indexed for MEDLINE]Related articles

    13.

    Targeting postprandial hyperglycemia.

    Rendell MS, Jovanovic L.

    Metabolism. 2006 Sep;55(9):1263-81. Review.PMID: 16919548 [PubMed - indexed for MEDLINE]Related articles

    14.

    Pharmacotherapies for diabetes management: an update for the practicing clinician.

    Meneghini L, Hirsch IB.

    Semin Thorac Cardiovasc Surg. 2006 Winter;18(4):379-89. Review.PMID: 17395035 [PubMed - indexed for MEDLINE]Related articles

    15.

    Glucose and insulin management in the post-MI setting.

    McNulty PH.

    Curr Diab Rep. 2002 Feb;2(1):37-44. Review.PMID: 12643121 [PubMed - indexed for MEDLINE]Related articles

    16.

    Exploiting the antidiabetic properties of incretins to treat type 2 diabetes mellitus: glucagon-like peptide 1 receptor agonists or insulin for patients with inadequate glycemic control?

    Van Gaal LF, Gutkin SW, Nauck MA.

    Eur J Endocrinol. 2008 Jun;158(6):773-84. Epub 2008 Mar 5. Review.PMID: 18322302 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Postprandial glycemia and cardiovascular disease in diabetes mellitus.

    Wajchenberg BL.

    Arq Bras Endocrinol Metabol. 2007 Mar;51(2):212-21. Review.PMID: 17505628 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Effect of the postprandial state on nontraditional risk factors.

    Lebovitz HE.

    Am J Cardiol. 2001 Sep 20;88(6A):20H-5H. Review.PMID: 11576522 [PubMed - indexed for MEDLINE]Related articles

    19.

    Diabetes: the latest trends in glycemic control.

    Giurini JM, Cook EA, Cook JJ.

    Clin Podiatr Med Surg. 2007 Apr;24(2):159-89. Review.PMID: 17430766 [PubMed - indexed for MEDLINE]Related articles

    20.

    Use of insulin to improve glycemic control in diabetes mellitus.

    Dandona P, Chaudhuri A, Ghanim H, Mohanty P.

    Cardiovasc Drugs Ther. 2008 Jun;22(3):241-51. Epub 2008 Mar 18. Review.PMID: 18347965 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity